SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $400,632 | -3.8% | 3,305 | -9.1% | 0.40% | +5.5% |
| Q2 2023 | $416,280 | -17.0% | 3,635 | -0.1% | 0.38% | -25.4% |
| Q1 2023 | $501,701 | +2.9% | 3,640 | -3.3% | 0.52% | 0.0% |
| Q4 2022 | $487,610 | +13.7% | 3,763 | -3.1% | 0.52% | +11.5% |
| Q3 2022 | $429,000 | +51.6% | 3,883 | +2.9% | 0.46% | +56.6% |
| Q2 2022 | $283,000 | -7.5% | 3,773 | -3.8% | 0.30% | +28.3% |
| Q1 2022 | $306,000 | -15.0% | 3,923 | -1.8% | 0.23% | -22.6% |
| Q4 2021 | $360,000 | – | 3,993 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
| Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
| Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
| NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
| Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
| Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
| CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
| RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
| Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |